More about

Obesity

News
October 08, 2024
3 min read
Save

Wegovy improves exercise function in obesity-related HF with concomitant weight loss

Wegovy improves exercise function in obesity-related HF with concomitant weight loss

Semaglutide 2.4 mg was linked to early, sustained improvement in exercise function among patients with obesity-related HF and improved most among those with the largest proportionate weight loss, a speaker reported.

News
October 08, 2024
3 min read
Save

Having three or more metabolic risk factors raises diabetes risk in people with HIV

Having three or more metabolic risk factors raises diabetes risk in people with HIV

In adults living with HIV, those with three or more metabolic risk factors had a higher risk for developing new-onset diabetes than those without any risk factors, according to new findings from the REPRIEVE trial.

News
October 04, 2024
2 min read
Save

Top news of September: Sunscreen, endocrine-disrupting chemicals, Ozempic, more

Top news of September: Sunscreen, endocrine-disrupting chemicals, Ozempic, more

The FDA’s inaction approving sunscreen ingredients as well as studies about endocrine-disrupting chemicals in personal care products and Ozempic’s impact on hidradenitis suppurativa led Healio Dermatology’s most-read articles in September.

News
October 04, 2024
2 min read
Save

Hepatic steatosis identified in more than half of younger adults without history of MASLD

Hepatic steatosis identified in more than half of younger adults without history of MASLD

Hepatic steatosis was prevalent among 52% of adults with or without type 2 diabetes and no known history of metabolic dysfunction-associated steatotic liver disease, according to findings published in Obesity.

News
October 03, 2024
1 min read
Save

FDA removes tirzepatide from drug shortage list

FDA removes tirzepatide from drug shortage list

Shortages of tirzepatide, a GIP/GLP-1 dual agonist approved for the treatment of type 2 diabetes and obesity, have been resolved, the FDA announced.

News
October 03, 2024
3 min read
Save

Tirzepatide, semaglutide more efficacious than other FDA-approved drugs for weight loss

Tirzepatide, semaglutide more efficacious than other FDA-approved drugs for weight loss

Tirzepatide and semaglutide confer greater weight loss than other FDA-approved obesity medications with no significantly higher risk for adverse events, according to findings from a network meta-analysis published in Obesity.

News
October 03, 2024
2 min read
Save

Obesity dampens rheumatoid arthritis treatment effectiveness, satisfaction

Obesity dampens rheumatoid arthritis treatment effectiveness, satisfaction

SAN DIEGO — Obesity represents a significant barrier to treatment effectiveness, and by extension treatment satisfaction, in rheumatoid arthritis, according to data presented at the 2024 Congress of Clinical Rheumatology West.

News
October 02, 2024
2 min read
Save

Osteoarthritis recommendations lack ‘granular guidance’ on exercise, weight loss

Osteoarthritis recommendations lack ‘granular guidance’ on exercise, weight loss

SAN DIEGO — Although most osteoarthritis experts agree that diet and exercise are critical to disease management, detailed guidance on either remain lacking, according to a presenter at the 2024 Congress of Clinical Rheumatology West.

News
October 02, 2024
3 min read
Save

AHA announces late-breaking lineup to be presented at 2024 Scientific Sessions

AHA announces late-breaking lineup to be presented at 2024 Scientific Sessions

The American Heart Association Scientific Sessions will be held in-person only in Chicago from Nov. 16 to 18 and will feature eight late-breaking science sessions during the 3-day meeting.

News
October 01, 2024
2 min read
Save

GLP-1RA use linked with risk for food retention in single endoscopic procedures

GLP-1RA use linked with risk for food retention in single endoscopic procedures

Use of glucagon-like peptide-1 receptor agonists was associated with an increased risk for gastric food retention during single endoscopic procedures, although this risk was low when combined with colonoscopy, according to research.

View more